Quest Diagnostics(NYSE: DGX), a leading provider of diagnostic information services, will host an Investor Day for institutional investors and financial analysts inNew York CityonThursday, March 19, 2025atthe New York Stock Exchange.
https://mma.prnewswire.com/media/200883/quest_diagnostics_incorporated_logo_logo.jpg
During the event,Jim Davis, Chairman, CEO and President,Sam Samad, Executive Vice President and CFO, and other senior executives will provide updated views of the U.S. laboratory market, and the company's business strategy, capital deployment priorities, and its long-term outlook.Advance registration is required.
To register for the event, please go to:Quest Diagnostics 2025 Investor Day Registration.
A live webcast of the event will be broadcast on the Quest Diagnostics Investor Relations website.
An archived copy of the webcast will be available on theQuest Diagnostics Investor Relations websitefollowing the conclusion of the event.
About Quest DiagnosticsQuest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest Diagnostics annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our more than 55,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives and create a healthier world.www.QuestDiagnostics.com.
https://c212.net/c/img/favicon.png?sn=NY19374&sd=2025-02-13
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-host-investor-day-on-march-19-2025-302376570.html
SOURCE Quest Diagnostics
https://rt.newswire.ca/rt.gif?NewsItemId=NY19374&Transmission_Id=202502131654PR_NEWS_USPR_____NY19374&DateId=20250213